袖状胃切除术与胃旁路术后5年安全性比较
该回顾性队列研究纳入美国国家Medicare索赔数据库中2012至2018年接受袖状胃切除术或胃旁路术的成人患者,采用工具变量生存分析比较术后5年结局。结果显示袖状胃切除术患者5年死亡率、并发症及再干预累积发生率更低,但手术修正率更高;住院和急诊使用在1年时较低,5年时两组相似。
要点
- 袖状胃切除术5年死亡率、并发症及再干预风险低于胃旁路术。
- 袖状胃切除术5年手术修正风险高于胃旁路术。
- 术后1年住院花费较低,3年和5年时总花费相似。
核心结论
- 袖状胃切除术与较低的长期死亡、并发症和再干预风险相关,但手术修正风险较高。
研究设计与样本
- 回顾性队列研究,纳入美国国家Medicare索赔数据库中2012年1月1日至2018年12月31日接受袖状胃切除术或胃旁路术的成人患者,共95 405例,其中袖状胃切除术57 003例,胃旁路术38 402例,采用工具变量生存分析估计术后5年累积发生率。
主要发现
- 术后5年袖状胃切除术患者死亡累积发生率为4.27%(95%CI 4.25%-4.30%),胃旁路术为5.67%(95%CI 5.63%-5.69%)。
- 术后5年袖状胃切除术患者并发症累积发生率为22.10%(95%CI 22.06%-22.13%),胃旁路术为29.03%(95%CI 28.99%-29.08%)。
- 术后5年袖状胃切除术患者再干预累积发生率为25.23%(95%CI 25.19%-25.27%),胃旁路术为33.57%(95%CI 33.52%-33.63%)。
- 术后5年袖状胃切除术患者手术修正累积发生率为2.91%(95%CI 2.90%-2.93%),胃旁路术为1.46%(95%CI 1.45%-1.47%)。
- 术后1年袖状胃切除术患者住院调整风险比aHR为0.83(95%CI 0.80-0.86),急诊使用aHR为0.87(95%CI 0.84-0.90);术后3年住院aHR为0.94(95%CI 0.90-0.98),急诊aHR为0.93(95%CI 0.90-0.97);术后5年住院aHR为0.99(95%CI 0.94-1.04),急诊aHR为0.97(95%CI 0.92-1.01)。
临床怎么用
- 在医患共同决策中,可将袖状胃切除术较低的长期死亡、并发症和再干预风险与较高的手术修正风险告知患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Sleeve gastrectomy is the most widely used bariatric operation; however, its long-term safety is largely unknown. OBJECTIVE: To compare the risk of mortality, complications, reintervention, and health care use 5 years after sleeve gastrectomy and gastric bypass. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included adult patients in a national Medicare claims database who underwent sleeve gastrectomy or gastric bypass from January 1, 2012, to December 31, 2018. Instrumental variables survival analysis was used to estimate the cumulative incidence of outcomes up to 5 years after surgery. EXPOSURES: Laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass. MAIN OUTCOMES AND MEASURES: The main outcome was risk of mortality, complications, and reinterventions up to 5 years after surgery. Secondary outcomes were health care use after surgery, including hospitalization, emergency department (ED) use, and total spending. RESULTS: Of 95 405 patients undergoing bariatric surgery, 57 003 (60%) underwent sleeve gastrectomy (mean [SD] age, 57.1 [11.8] years), of whom 42 299 (74.2%) were women; 124 (0.2%) were Asian; 10 101 (17.7%), Black; 1951 (3.4%), Hispanic; 314 (0.6%), North American Native; 43 194 (75.8%), White; 534 (0.9%), of other race or ethnicity; and 785 (1.4%), of unknown race or ethnicity. A total of 38 402 patients (40%) underwent gastric bypass (mean [SD] age, 55.9 [11.7] years), of whom 29 050 (75.7%) were women; 109 (0.3%), Asian; 6038 (15.7%), Black; 1215 (3.2%), Hispanic; 278 (0.7%), North American Native; 29 986 (78.1%), White; 373 (1.0%), of other race or ethnicity; and 404 (1.1%), of unknown race or ethnicity. Compared with patients undergoing gastric bypass, at 5 years after surgery, patients undergoing sleeve gastrectomy had a lower cumulative incidence of mortality (4.27%; 95% CI, 4.25%-4.30% vs 5.67%; 95% CI, 5.63%-5.69%), complications (22.10%; 95% CI, 22.06%-22.13% vs 29.03%; 95% CI, 28.99%-29.08%), and reintervention (25.23%; 95% CI, 25.19%-25.27% vs 33.57%; 95% CI, 33.52%-33.63%). Conversely, patients undergoing sleeve gastrectomy had a higher cumulative incidence of surgical revision at 5 years (2.91%; 95% CI, 2.90%-2.93% vs 1.46%; 95% CI, 1.45%-1.47%). The adjusted hazard ratio (aHR) of all-cause hospitalization and ED use was lower for patients undergoing sleeve gastrectomy at 1 year (hospitalization, aHR, 0.83; 95% CI, 0.80-0.86; ED use, aHR, 0.87; 95% CI, 0.84-0.90) and 3 years (hospitalization, aHR, 0.94; 95% CI, 0.90-0.98; ED use, aHR, 0.93; 95% CI, 0.90-0.97) after surgery but similar between groups at 5 years (hospitalization, aHR, 0.99; 95% CI, 0.94-1.04; ED use, aHR, 0.97; 95% CI, 0.92-1.01). Total health care spending among patients undergoing sleeve gastrectomy was lower at 1 year after surgery ($28 706; 95% CI, $27 866-$29 545 vs $30 663; 95% CI, $29 739-$31 587), but similar between groups at 3 ($57 411; 95% CI, $55 239-$59 584 vs $58 581; 95% CI, $56 551-$60 611) and 5 years ($86 584; 95% CI, $80 183-$92 984 vs $85 762; 95% CI, $82 600-$88 924). CONCLUSIONS AND RELEVANCE: In a large cohort of patients undergoing bariatric surgery, sleeve gastrectomy was associated with a lower long-term risk of mortality, complications, and reinterventions but a higher long-term risk of surgical revision. Understanding the comparative safety of these operations may better inform patients and surgeons in their decision-making.
引用
- Howard R, Chao GF, Yang J, et al. Comparative Safety of Sleeve Gastrectomy and Gastric Bypass Up to 5 Years After Surgery in Patients With Severe Obesity. JAMA Surg. 2021. PMID: 34613354. doi:10.1001/jamasurg.2021.4981
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。